Ondena en es it fr

Ondena Brand names, Ondena Analogs

Ondena Brand Names Mixture

  • No information avaliable

Ondena Chemical_Formula


Ondena RX_link


Ondena fda sheet


Ondena msds (material safety sheet)

Ondena MSDS

Ondena Synthesis Reference

J. P. Parsh et al. J. Pharm. Sci. 56, 1691 (1967);

Ondena Molecular Weight

527.52 g/mol

Ondena Melting Point

208-209 oC

Ondena H2O Solubility

39.2 mg/L

Ondena State


Ondena LogP


Ondena Dosage Forms

Powder for solution; Suspension

Ondena Indication

For remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.

Ondena Pharmacology

Daunorubicin is an antineoplastic in the anthracycline class. General properties of drugs in this class include: interaction with DNA in a variety of different ways including intercalation (squeezing between the base pairs), DNA strand breakage and inhibition with the enzyme topoisomerase II. Most of these compounds have been isolated from natural sources and antibiotics. However, they lack the specificity of the antimicrobial antibiotics and thus produce significant toxicity. The anthracyclines are among the most important antitumor drugs available. Doxorubicin is widely used for the treatment of several solid tumors while daunorubicin and idarubicin are used exclusively for the treatment of leukemia. Daunorubicin may also inhibit polymerase activity, affect regulation of gene expression, and produce free radical damage to DNA. Daunorubicin possesses an antitumor effect against a wide spectrum of tumors, either grafted or spontaneous. The anthracyclines are cell cycle-nonspecific.

Ondena Absorption

No information avaliable

Ondena side effects and Toxicity

LD50=20 mg/kg (mice, IV); LD50=13 mg/kg (rat, IV)

Ondena Patient Information

Ondena Organisms Affected

Humans and other mammals